Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | H LUNDBECK A/S: Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck | 2 | Cision News | ||
07.05. | A surprise leader for April's largest TV drug ad spender as Otsuka, Lundbeck knock AbbVie from its perch | 6 | FiercePharma | ||
24.04. | GSK, Lundbeck, ROVI: Three Journeys of Unified Pharma Events Management | 9 | Pharmaceutical Technology | ||
09.04. | H LUNDBECK A/S: Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD | 88 | Cision News | ||
28.03. | Otsuka and Lundbeck's schizophrenia treatment gains EC approval | 4 | Pharmaceutical Technology | ||
27.03. | H LUNDBECK A/S: Abilify Maintena[®] 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of schizophrenia | 1 | Cision News | ||
20.03. | H LUNDBECK A/S: Lundbeck held its Annual General Meeting on 20 March 2024 at the company's registered office | 2 | Cision News | ||
15.03. | H LUNDBECK A/S: Lundbeck's potential first-in-class therapy for migraine prevention enters advanced clinical stage | 2 | Cision News | ||
06.03. | Lundbeck Foundation: -Pionierarbeit auf dem Gebiet der rechnergestützten und theoretischen Neurowissenschaften wird mit dem weltweit größten Preis für Hirnforschung ausgezeichnet | 409 | Business Wire | Die Professoren Larry Abbott, Terrence Sejnowski und Haim Sompolinsky haben Pionierarbeit auf dem Gebiet der rechnergestützten und theoretischen Neurowissenschaften geleistet und entscheidende Beiträge... ► Artikel lesen | |
05.03. | Lundbeck Foundation: Pioneering work in computational and theoretical neuroscience is awarded the world's largest brain research prize | 269 | Business Wire | Professors Larry Abbott, Terrence Sejnowski, and Haim Sompolinsky have pioneered the field of computational and theoretical neuroscience and made seminal contributions to our understanding of the... ► Artikel lesen | |
05.03. | H LUNDBECK A/S: Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders | 3 | Cision News | ||
23.02. | H LUNDBECK A/S: Notice of Annual General Meeting | 2 | Cision News | ||
23.02. | H LUNDBECK A/S: Lundbeck announces changes to Executive Management | 4 | Cision News | ||
16.02. | H LUNDBECK A/S: Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties | 3 | Cision News | ||
13.02. | DB upgrades Lundbeck to 'buy' on promising drug prospects in 2024 | 10 | Reuters | ||
07.02. | H LUNDBECK A/S: Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties | 7 | Cision News | ||
07.02. | H LUNDBECK A/S: Lundbeck Annual Report 2023 | 9 | Cision News | ||
05.02. | H LUNDBECK A/S: Dianne Hol appointed new Executive Vice President People & Organization at Lundbeck | 2 | Cision News | ||
01.02. | Lundbeck study knocks confidence in alpha-syn as CNS target | 4 | pharmaphorum | ||
31.01. | H LUNDBECK A/S: Lundbeck announces supportive phase II results with Lu AF82422 in the treatment of Multiple System Atrophy from the AMULET trial | 4 | Cision News |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 3.191 |
TUI | 2.227 |
BAYER | 2.218 |
NEL | 1.888 |
PLUG POWER | 1.685 |
GAMESTOP | 1.501 |
RHEINMETALL | 1.376 |
SIEMENS ENERGY | 1.320 |
NVIDIA | 1.189 |
NOVAVAX | 1.149 |
MERCEDES-BENZ | 1.081 |
DEUTSCHE BANK | 891 |
AMC ENTERTAINMENT | 851 |
NORDEX | 827 |
BYD | 822 |
ALIBABA | 798 |
TESLA | 780 |
PALANTIR TECHNOLOGIES | 748 |
VOLKSWAGEN | 737 |
ALLIANZ | 714 |
AIXTRON SE | 699 |
RWE | 691 |
K+S | 623 |
COMMERZBANK | 621 |
DEUTSCHE LUFTHANSA | 599 |